Body Mass Index and the Association With Vaso-occlusive Crises in Pediatric Sickle Cell Disease

Andrea Zivot1, Nataly Apollonsky, Edward Gracely

  • 1*Einstein Healthcare Network †St. Christopher's Hospital for Children, Drexel University ‡Department of Pediatrics, Drexel University, Philadelphia, PA.

Insights

Obesity in children with sickle cell disease (SCD) did not increase hospitalizations for vaso-occlusive crisis (VOC). However, obesity was more common in those with HbSC genotype compared to HbSS.

Area of Science:

  • Pediatric Hematology
  • Sickle Cell Disease Research
  • Obesity in Chronic Illness

Background:

  • Children with sickle cell disease (SCD) traditionally exhibit underweight and poor growth.
  • Recent trends indicate a rise in obesity among pediatric SCD populations.

Purpose of the Study:

  • To investigate the association between body mass index (BMI) extremes and hospitalizations for vaso-occlusive crisis (VOC) in pediatric SCD patients.
  • To explore correlations between BMI, SCD genotype, and VOC-related hospitalizations.

Main Methods:

  • Retrospective chart review of 328 pediatric SCD patients.
  • Data collected included BMI, weight percentiles, SCD genotype, hemoglobin levels, comorbidities, vitamin D levels, hydroxyurea treatment, and chronic transfusions.
  • Statistical analyses (t test, Mann-Whitney U, ANOVA) were used to examine associations with VOC frequency and duration.

Main Results:

  • Overweight and obese children comprised 19% of the study cohort.
  • BMI status did not significantly affect the frequency or duration of VOC hospitalizations (P=0.90 and P=0.65, respectively).
  • Obesity showed a stronger association with HbSC genotype compared to HbSS genotype (P=0.025).

Conclusions:

  • This study found no significant association between extreme BMI and VOC hospitalizations in pediatric SCD.
  • Further prospective research is needed to understand the impact of obesity on pain crises in SCD, given the rising obesity trend.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
286
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
5.5K